The dust has yet to settle on a report warning that the international community is ill-prepared to face another infectious disease outbreak and suddenly we are staring down the barrel of a Zika pandemic.
The World Health Organization (WHO) said it is “deeply concerned” by the situation in Latin America, which director-general Dr Margaret Chan described as “explosive.”
Latest figures estimate that as many as four million people could be affected by the mosquito-borne virus which has been linked to thousands of birth defects and cases of Guillain-Barré syndrome, a poorly understood condition in which the immune system attacks the nervous system, sometimes resulting in paralysis.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze